Letrozole-d4 (major)

CAS: 1133712-96-5

Ref. 3D-IVB71296

Produktinformation

• Name: Letrozole-d4 (major)

Beschreibung

Letrozole D4 is a synthetic hormone that belongs to the group of aromatase inhibitors. It is used to treat breast cancer in postmenopausal women. Letrozole D4 has been shown to be equivalent to letrozole for the treatment of breast cancer. It is administered orally and can be detected in the plasma at concentrations of 1-10 ng/mL, which are detectable for 24 hours after administration. Letrozole D4 has also been shown to have an adverse effect on body mass index (BMI) and symptoms related to estrogen deficiency such as hot flashes, mood swings, and vaginal dryness.

• Marke: Biosynth

Chemische Eigenschaften

• Molekulargewicht: 289.33 g/mol
• Formel: C₁₇H₁₁N₅
• Reinheit: Min. 95%